The HHS ‘Price Transparency’ Rule Is a New Assault on Drug Makers

The Biden Administration is waging a relentless regulatory assault on drug makers, mostly under media radar. The latest front is the Health and Human Services Department’s new “price transparency” rule that seeks to dun drug makers to pay for Medicaid.#medicaid

Source: Reuters: Health - June 2, 2023 Category: Consumer Health News Source Type: news